Actively Recruiting
Adaptive Neuromodulation of Working Memory Networks in Aging and Dementia
Led by Duke University · Updated on 2025-10-14
150
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
D
Duke University
Lead Sponsor
N
National Institute on Aging (NIA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating the use of closed-loop transcranial magnetic stimulation (TMS) based on personalized brain networks to control brain states related to working memory in healthy older adults and those with mild cognitive impairment (MCI). The study aims to understand brain network activation and neural oscillations in the prefrontal cortex, which regulates working memory, and to test how TMS affects memory performance and brain activity. This research addresses challenges in previous TMS studies by using individualized brain models and considering cerebrovascular effects in aging and MCI. Participants will receive one of three closed-loop TMS treatments triggered by alpha-band brain activity: arrhythmic TMS intended to disrupt alpha oscillations and potentially enhance memory, rhythmic alpha-frequency TMS expected to synchronize brain activity and possibly reduce memory performance, or sham stimulation with no actual brain stimulation. The study uses advanced brain imaging and monitoring techniques including concurrent TMS-fMRI and TMS-EEG to map dose-response relationships and neural network dynamics during working memory tasks. During the study, participants will undergo screening and multiple neuroimaging sessions to assess brain connectivity and vascular density, followed by TMS-EEG sessions to evaluate working memory performance and EEG-based connectivity. Cognitive assessments such as the Montreal Cognitive Assessment and various memory and executive function tests will also be conducted. Researchers will monitor neural activity and working memory outcomes to understand the effects of TMS and to develop precise brain stimulation protocols for potential future clinical use. The study runs until June 2027 and involves adults aged 18 to 75 years.
CONDITIONS
Brief Title
Neuromodulation of Memory in Aging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- English speaking
- Willing to provide consent
- Age between 18 and 75 years
You will not qualify if you...
- History of any Axis I DSM-V disorder, excluding major depressive disorder or generalized anxiety disorders
- Current history of substance abuse or dependence (excluding nicotine)
- Intracranial implants such as aneurysm clips, shunts, stimulators, cochlear implants, or electrodes
- Presence of cardiac pacemakers or vagus nerve stimulation devices
- Increased risk of seizure from epilepsy, seizure disorder, increased intracranial pressure, or significant head trauma with loss of consciousness for 5 minutes or more
- Neurological disorders including brain lesions, seizures, stroke, fainting, cerebral aneurysm, dementia, Huntington chorea, or multiple sclerosis
- Current use of medications known to lower seizure threshold or affect working memory
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 days
Participants receive noninvasive transcranial magnetic stimulation (TMS) to modulate brain activity in the prefrontal cortex to study its effects on working memory and brain network function.
4 visits including neuroimaging and TMS-EEG sessions
Trial Site Locations
Total: 1 location
1
Duke University Hospital
Durham, North Carolina, United States, 27710
Actively Recruiting
Research Team
S
Simon W Davis, PhD
E
Emily Finch, BA
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here